Issue Date: August 21, 2017 | Web Date: August 20, 2017
Pfizer expands plant in North Carolina
Pfizer will spend $100 million to expand its gene therapy manufacturing facility in Sanford, N.C. Pfizer acquired the plant last year as part of its purchase of Bamboo Therapeutics, a gene therapy developer founded by three University of North Carolina, Chapel Hill, scientists. The facility uses adeno-associated viruses to deliver genes that teach cells how to make missing or defective proteins. Only one gene therapy, the rare-disease treatment Glybera, has been approved in the U.S. or Europe.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society